Skip to main content
logo
Aptus Pharma Limited (BOM:544529)
India flag India · Delayed Price · Currency is INR
472.10
-9.60 (-1.99%)
At close: Oct 27, 2026

Aptus Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
811.18465.75245.58178.57138.97105.07
Revenue Growth
74.17%89.65%37.52%28.49%32.27%106.18%
Gross Profit
374.14251.76154.81110.3191.3566.76
Operating Income
117.9870.4645.8413.784.762.37
Net Income
79.546.2318.62.431.01
Earnings Per Share
4.663.112.552.291.330.55
EPS Growth
49.87%22.13%11.13%72.44%140.87%125.39%

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
18.0210.2752.149.145.372.61
Total Debt
121.1171.82103.5753.0822.1212.58
Net Cash (Debt)
-103.09-61.55-51.43-43.94-16.75-9.98
Net Cash Growth
------
Net Cash Per Share
-6.05-4.15-4.23-11.71-9.17-5.46

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-114.85-56.03-18.38-21.75-1.81-
Capital Expenditures
-25.9-21.86-6.22-3.3-3.53-
Free Cash Flow
-140.76-77.89-24.6-25.04-5.34-
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
46.12%54.05%63.04%61.77%65.73%63.54%
Operating Margin
14.54%15.13%18.67%7.72%3.43%2.26%
Pretax Margin
13.38%13.69%17.08%6.52%2.40%1.39%
Profit Margin
9.80%9.92%12.62%4.82%1.75%0.96%
FCF Margin
-17.35%-16.72%-10.02%-14.02%-3.84%-

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
101.2251.85----
PS Ratio
9.985.14----